Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.43
+0.03 (0.41%)
At close: Nov 11, 2026, 4:00 PM EST
7.25
-0.18 (-2.42%)
Pre-market: Nov 12, 2026, 4:08 AM EST
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $101.82 million as of November 11, 2026. It is the 24,871st most valuable company in the world and the 4,047th biggest in the United States. Its market cap has increased by 651.00% in one year.
Market Cap
101.82M
Enterprise Value
55.55M
1-Year Change
651.00%
Global Rank
Country Rank
#4,047 United States
Category
ChartMarket Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has decreased from $141.44M to $101.82M, a decrease of -28.01%. That is a compound annual growth rate of -1.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 101.82M | 30.36% |
| Dec 31, 2025 | 78.10M | 913.26% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 106.72M |
| Anavex Life Sciences | 104.75M |
| Vivani Medical | 103.73M |
| Unicycive Therapeutics | 101.81M |
| NRx Pharmaceuticals | 101.67M |
| NovaBridge Biosciences | 100.49M |
| Coherus Oncology | 99.04M |
| Retension Pharmaceuticals | 98.81M |